Docsity
Docsity
Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity

Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan

Guidelines and tips
Guidelines and tips
Sell on Docsity
Sell on Docsity
Docsity AI
Docsity AI
Log inSign up

Prepare for your exams

Study with the several resources on Docsity

Find documents

Prepare for your exams with the study notes shared by other students like you on Docsity

Search for your university

Find the specific documents for your university's exams

Docsity AINEW

Summarize your documents, ask them questions, convert them into quizzes and concept maps

Explore questions

Clear up your doubts by reading the answers to questions asked by your fellow students

Earn points to download

Earn points by helping other students or get them with a premium plan

Share documents
download point icon20 Points

For each uploaded document

Answer questions
download point icon5 Points

For each given answer (max 1 per day)

All the ways to get free points
Get points immediately

Choose a premium plan with all the points you need

Study Opportunities

Choose your next study program

Get in touch with the best universities in the world. Search through thousands of universities and official partners

Community

Ask the community

Ask the community for help and clear up your study doubts

Free resources

Our save-the-student-ebooks!

Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors

Biology cellular controll, Study notes of Biology

Biology

biology cellular controll for a levels

Typology: Study notes

2023/2024

Uploaded on 05/09/2026

niyah-gababe
niyah-gababe šŸ‡¬šŸ‡§

4 documents

1 / 5

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
*P62581A02160* Turn over
21
DO NOT WRITE IN THIS AREA DO NOT WRITE IN THIS AREA DO NOT WRITE IN THIS AREA
DO NOT WRITE IN THIS AREA DO NOT WRITE IN THIS AREA DO NOT WRITE IN THIS AREA
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT
AOI
sunoda
AU3
ā†‘
conclusion
x
3
Gue
&
If
Okras
one
Biolgical
treatment
for
Anorexia
Eloretta
powes
Guardia
Bachie
Anorexia
affect
Around
0
.
3
%
g
the
population
with
it
featuring
An
onset
age
as
eary
as
11
.
It
effects
A
ratio
&
10
women
to
one
men
And
Often
develops
feelings
&
body
dismorphia
,
which
can
lead
to
weight
loss
leading
to
symptoms
such
as
Ammoneran
And
pale
skin
Biological
chemicals
such
as
"SAUs"
which
Are
second
generation
Anipsychotics
work
on
the
basis
g
restoring
herochemical
imbalances
,
or
causing
them
in
order
to
create
feeling
g
hunger
that
is
unable
to
be
natuary
created
by
An
suggezers
.
However
the
log
these
Antisychotics
Can
cause
ungotinate
side
effects
.
It
is
said
that
blockage
g
dopamine
receptor
in
the
basal
ganglia
causes
motor
side
eggess
,
Which
can
reduce
the
Appeal
I
taking
those
drys
As
side
get
Seem
to
odweigh
treatment
result
.
Although
you
could
Argue
that
Drugs
are
eygerive
As
the
treatments
such
as
token
ecorum
take
a
long
period
to
see
efferincess
,
with
development
g
treatment
varying
between
different
Clinical
insitutions
,
the
lac
&
Standardization
y
pf3
pf4
pf5

Partial preview of the text

Download Biology cellular controll and more Study notes Biology in PDF only on Docsity!

DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA

AOI PMT

sunoda AU3 ā†‘ conclusion

x 3

Gue& If Okras one Biolgical treatment^ for Anorexia Elorettapowes GuardiaBachie Anorexia (^) affect Around 0.^3 %^ g the (^) population with it (^) featuring An onset (^) age as^ eary as^11.^ It effectsAratio^ & 10 women^ to^ one^ menAnd Often develops^ feelings& (^) body dismorphia , which can lead^ to weight

loss

leading

to

symptoms such^ as^ Ammoneran^ And^ pale^ skin Biological chemicals^ such^ as "SAUs"^ which Are second (^) generation Anipsychotics

work on the

basis g restoring^ herochemical imbalances^ , or causing them in^ order^ to^ create^ feeling g hunger that is^ unable to^ be natuary created by An suggezers

However the^ log these Antisychotics Can cause ungotinate side effects

. Itis (^) said (^) that blockage g dopamine^ receptor^ in the^ basal^ ganglia causes motor^ side^ eggess , Which^ can^ reduce the (^) Appeal (^) I taking those^ drys As^ side^ get Seem to odweigh treatment (^) result. Although (^) you could Argue that (^) Drugs are eygerive Asthe treatments^ such^ as^ token^ ecorum take a (^) long period to^ see^ efferincess ,^ with development g treatment (^) varying between^ different Clinical insitutions^ , the lac^ & Standardization y

DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA

toen economy due^ to^ the use (^) g social conrol & psychologist^ ,^ training^ of healthcare (^) proffesiontle And daiy stuctures G linical (^) seth; means that we Are inable to^ decide^ weather^ token^ sconmy is eggorive as a^ treatment^ Alone^ or^ Along win Any one (^) situational (^) factors. Athough drus can^ lead to (^) moter side^ eg dus to blocinage in the basal ganglia ,^ itis fair to^ Say that^ drugs AreA^ more^ effective treatment as^ the^ chemical^ composition is kept consistent^ ,^ andAmount^ and^ consistency & ) prescription^ is^ aligned him^ specific circumstance making it a^ more^ valid^ treatment , one drug in specific is (^) Olanzapine (^) , Glanzapine is a second^ generation (^) Antipsychotic responsibly far (^) creating feelingsg hunger. It (^) does (^) this by binding^ to (^) complemens y proviens (also^ known^ as^ D2^ +^ Ds receptors^ ( which allous^ dazapine to^ act^ asAn anigon is tu dopamine. This (^) allows for An increase me exitoy tinbibity nerotansmitter (^) dopamine (^) , allowing far feelingsg revards^ unen^ earing good

. (^) This is because^ dopamine within^ the^ limbic (^) system, Specifically the revard^ pathun allouse (^) for

DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA

So amoyh powers^ et al (^) provide stig empeical evidence olanzapine^ him (^) weight gain his is (^) limited by turotena uno proposal fund that the (^) Greatment gAn was (^) eyered by the (^) basis gage as the stated it^ is^ more -efgerive in (^) Adul (^) , which limits the gapplicably 0.^3 %^ g me g power^ et al findings As from UK) (^) population , majoriy Most^ Anorexic Sufferes Are Yong Adolecent girls 2Asy Another Specific Drug re SSRIs SSRIs , (^) specifically seeronin^ reprams innibiy block b-HTLA (^) recepts unich (^) preveny the uphine g sereionin. & Severonin allAsAn exity nerone and (^) acn by binding to compleme reseptss^ on^ my^ sympse. the (^) blockage g b-HT2) (^) reseptus leads to A Chronic (^) exces g seretonin within^ the^ synapse , which causes desenserisation sereronin receptos. This (^) desenseristian reduces sensetiuness g receptos which^ leads^ to^ feeling (^) g hunger due to failre to signal feeling g^ Staity or in^ other words "feeling (^) hingry"

P62581A02260

DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA DO NO T WRITE IN THIS AREA

(Total for Question 6 = 20 marks) TOTAL FOR SECTION A = 54 MARKS One supporting study^ is from Kage et^ al^ , Kaye et al fund mat (^) when comparing A plasebo to (^) the (^) SSRI fleroxine ,^ the feruxine (^) group had^ a^ higher weight gain Over a^ one (^) year period. This (^) show that token (^) economy is an effire

rearment in gainin weight However sonoda^ et^ al^ fond that a^ case study g An 11 year old girls on token^ ecory lead to^ weight gain g lk)^ per^ monie And 25 , within monic This (^) conrasts with unde toretalia proposed that (^) age due^ to^ depamine development coributed to^ reament^ with^ it^ being more efjerive in Adua, However^ sonodo^ found taken econy to (^) be effotive on a^ girl as Yong as^10 , (^) deeming it^ more^ efserive man Drug Terepy as it^ seems to bypass the egger gindividas^ differences^ Such As^ Age perhaps due to itsNolisic Anne Overall Drug therepy^ is (^) egerive in^ manking weight aswell as increasing it^ by tajeri^ peronemical^ mechanisms^ him the (^) limbic system ,^ however^ is^ limited by its (^) gatives to accunt (^) for individas (^) differences-